HTD Biosystems, is a contract formulation development lab located in Livermore, California. HTD has worked and collaborated with large companies, governments, and academia. Our researchers have helped other companies develop their products. An example of a product that was formulated and developed at HTD Biosystems for a Japanese biotech company, is a liposomal formulation against graft-versus-host disease (GvHD) associated with hematopoietic stem cell transplantation (HSCT). This product is now in Phase II clinical trials.
Find out more about HTD Biosystems on our corporate website